NEW YORK, Oct. 6, 2025 — OraLiva, Inc., an AI precision diagnostics company, today announced the close of a $2.0 million oversubscribed Seed financing round. The round was led by angel Dr. Preetpal Sidhu, with participation from DCVC, RTP Angel Fund, and the NYU Innovation Venture Fund. The equity financing complements $3.5 million in non-dilutive […]
OraLiva awarded $1.9M National Institute of Dental and Craniofacial Research (NIDCR at NIH) Direct to Phase II SBIR grant for AI-linked cytomics-on-a-chip Read More